Christina Curtis, PhD, MSc, is an Associate Professor and Endowed Scholar in the Departments of Medicine and Genetics at Stanford University, where she leads the Cancer Computational and Systems Biology group. Dr. Curtis also serves as Director of Breast Cancer Translational Research and Co-Director of the Molecular Tumor Board at the Stanford Cancer Institute. Dr. Curtis’ laboratory leverages genome-scale data and computational modeling to define the molecular determinants and dynamics of tumor progression and to identify predictive biomarkers. Her research has helped to redefine the molecular map of breast cancer and led to new paradigms in understanding how human tumors evolve and metastasize. Dr. Curtis is the recipient of awards from the V Foundation for Cancer Research, STOP Cancer, American Association for Cancer Research, and is a Kavli Fellow of the National Academy of Sciences. She received the NIH Directors’ Pioneer award in 2018 and was named a Susan G. Komen Scholar in 2020. Dr. Curtis is a scientific advisor to multiple biotech and academic institutes and is an editorial board member of journals spanning computational biology to precision oncology.